How Many People Got The J&J COVID Vaccine?

blood clot vaccine

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.

Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.htmlexternal icon.

CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.

Popular Posts

Topics

Activist Advertising Air Quality Alchohol Antibody Antitrust Apple Apps Arizona Bankruptcy Banks Bars BBB Beaches Ben Shapiro Biden Big Pharma Bill Gates Blackmail blood clots Business California Cares Act CDC Censorship Chart Children China Class Action Closures CNN Contact Tracing Corruption Cover Up Data Deaths Doctors DOJ Dominion Drugs Education Election Elon Musk Email Enforcement Facebook Fake Laws Fake News Fake Tests Fake Vaccine False Positive Famotidine Fauci FBI FDA Fear Mongering Federal Reserve Feds Fines Florida Flu Flu Shots Fox Fraud Free Speech Freedom FTC Gavin Newsom Genome Glenn Beck Google Government Guillain-Barré Halloween Harvard Health Department Healthcare Herd Immunity Hospitals Hydroxychloroquine Insurance Investment IRS J&J Jeff Bezos Jobs LA County Lawsuits Leadership Lies Loans Local Laws Lockdown Los Angeles Map Masks Media Medicaid Melatonin Mental Health Michigan Minnesota Nashville New Jersey New York NFL Nursing Homes NY Post Opinion Opposing View Oppression Outdoors Parks Pennsylvania Phishing Placebo Pneumonia Politics Poll Pollution PPP Prevention Project Veritas Protest Rand Paul Real Estate Regeneron Relief Checks Remdesirvir Restaurants Restraining Order Rudy Giuliani Safegraph SBA Scams Schools Science Seniors Sidney Powell Social Distancing South Korea Sports Stadiums Stay at Home Study Substance Abuse Surveillance Sweden Symptoms Taxes Technology Testing Texas Tips Tony Bobulinski Transmission Treatment Trojan Horse Trump Tucker Carlson Twitter Tyranny Unemployment Vaccine Video Vitamin D Warren Buffett Whistleblower WHO Wisconsin Workers Comp Zinc